K Raymond

597 total citations
27 papers, 452 citations indexed

About

K Raymond is a scholar working on Analytical Chemistry, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, K Raymond has authored 27 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Analytical Chemistry, 9 papers in Pharmacology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in K Raymond's work include Analytical Methods in Pharmaceuticals (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pharmaceutical studies and practices (6 papers). K Raymond is often cited by papers focused on Analytical Methods in Pharmaceuticals (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pharmaceutical studies and practices (6 papers). K Raymond collaborates with scholars based in Hong Kong, United Kingdom and Australia. K Raymond's co-authors include John E. Sanderson, M. R. Howard, R. L. Parsons, T R Shaw, Kam S. Woo, C M Castleden, Paul Turner, C M Kaye, DJ Morgan and John Hamer and has published in prestigious journals such as The Lancet, Gut and Coordination Chemistry Reviews.

In The Last Decade

K Raymond

27 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Raymond Hong Kong 13 120 66 65 55 51 27 452
Pekka Ottoila Finland 12 154 1.3× 39 0.6× 64 1.0× 45 0.8× 28 0.5× 19 506
Clarence T. Ueda United States 13 137 1.1× 55 0.8× 75 1.2× 77 1.4× 39 0.8× 39 626
Chii‐Ming Lai United States 14 147 1.2× 106 1.6× 107 1.6× 56 1.0× 76 1.5× 36 660
Dale A. Raines Saudi Arabia 13 75 0.6× 87 1.3× 102 1.6× 37 0.7× 43 0.8× 25 448
D W Holt United Kingdom 14 233 1.9× 46 0.7× 113 1.7× 88 1.6× 90 1.8× 48 768
Henry J. Pieniaszek United States 15 173 1.4× 61 0.9× 132 2.0× 60 1.1× 113 2.2× 45 699
J.‐M. POIRIER France 16 221 1.8× 64 1.0× 119 1.8× 52 0.9× 37 0.7× 38 697
John J. Schrogie United States 14 86 0.7× 41 0.6× 154 2.4× 81 1.5× 40 0.8× 34 688
Richard H. Reuning United States 15 102 0.8× 143 2.2× 133 2.0× 124 2.3× 51 1.0× 45 809
S. M. Singhvi United States 12 113 0.9× 75 1.1× 118 1.8× 105 1.9× 124 2.4× 24 632

Countries citing papers authored by K Raymond

Since Specialization
Citations

This map shows the geographic impact of K Raymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Raymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Raymond more than expected).

Fields of papers citing papers by K Raymond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Raymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Raymond. The network helps show where K Raymond may publish in the future.

Co-authorship network of co-authors of K Raymond

This figure shows the co-authorship network connecting the top 25 collaborators of K Raymond. A scholar is included among the top collaborators of K Raymond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Raymond. K Raymond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saslow, Laura R., Sarah Kim, Frederick Hecht, et al.. (2023). Psychological Support Strategies for Adults With Type 2 Diabetes in a Very Low–Carbohydrate Web-Based Program: Randomized Controlled Trial. JMIR Diabetes. 8. e44295–e44295. 4 indexed citations
2.
Chan, Wing Hong, Youyong Kong, K Raymond, et al.. (1998). Use of indapamide in hospital and community clinics and its effect on plasma potassium in Chinese patients. Journal of Clinical Pharmacy and Therapeutics. 23(4). 295–302. 7 indexed citations
3.
Raymond, K, et al.. (1997). Efficient assay for the determination of atenolol in human plasma and urine by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 691(2). 473–477. 24 indexed citations
4.
Wong, Jonathan W.C., et al.. (1997). Overview of the Hospital Formulary Systems in Hong Kong: Princess Margaret Hospital as a Baseline. Annals of Pharmacotherapy. 31(12). 1526–1531. 3 indexed citations
5.
Raymond, K, et al.. (1996). Validated assay for the determination of celiprolol in plasma using high-performance liquid chromatography and a silanol deactivated reversed-phase support. Journal of Chromatography B. 687(2). 462–465. 6 indexed citations
6.
Raymond, K, et al.. (1996). Validated assay for the determination of celiprolol in plasma using high-performance liquid chromatography and a silanol deactivated reversed-phase support. Journal of Chromatography B Biomedical Sciences and Applications. 687(2). 462–465. 11 indexed citations
7.
8.
McNeil, John J., Olaf H. Drummer, K Raymond, E. L. Conway, & Louis Wj. (1991). The influence of food on the oral bioavailability of terazosin [letter]. British Journal of Clinical Pharmacology. 32(6). 775–776. 3 indexed citations
9.
Conway, E. L., John J. McNeil, Meng Lu, et al.. (1989). Single-Dose and Steady-State Pharmacokinetics of Doxazosin Given in Combination with Chlorothiazide to Hypertensive Subjects. Clinical Pharmacokinetics. 16(6). 387–391. 4 indexed citations
10.
Morgan, DJ, et al.. (1984). Influence of chronic dosing on theophylline clearance.. British Journal of Clinical Pharmacology. 17(5). 525–530. 15 indexed citations
11.
Morgan, Denis J., et al.. (1983). The influence of duration of intravenous infusion of an acute dose on plasma concentrations of cimetidine. European Journal of Clinical Pharmacology. 25(1). 29–34. 1 indexed citations
12.
Morgan, Denis J. & K Raymond. (1980). Evaluation of slow infusions of co-trimoxazole by using predictive pharmacokinetics. Antimicrobial Agents and Chemotherapy. 17(2). 132–137. 10 indexed citations
13.
Parsons, R. L., et al.. (1980). Pharmacokinetics of intravenous erythromycin lactobionate.. PubMed. 8 Suppl 2. 15–23. 11 indexed citations
14.
Parsons, R. L., C M Kaye, & K Raymond. (1977). Pharmacokinetics of salicylate and indomethacin in coeliac disease. European Journal of Clinical Pharmacology. 11(6). 473–477. 12 indexed citations
15.
Parsons, R. L., C M Kaye, K Raymond, J.R. Trounce, & Paul Turner. (1976). Absorption of propranolol and practolol in Coeliac disease.. Gut. 17(2). 139–143. 24 indexed citations
16.
Raymond, K, et al.. (1975). The effect of buffered aspirin on plasma indomethacin. European Journal of Clinical Pharmacology. 8(2). 107–113. 20 indexed citations
17.
Raymond, K, et al.. (1974). The biological availability of very rapidly dissolving digoxin tablets.. PubMed. 50 Suppl 6. 55–9. 3 indexed citations
18.
Shaw, T R, J E Carless, M. R. Howard, & K Raymond. (1973). PARTICLE SIZE AND ABSORPTION OF DIGOXIN. The Lancet. 302(7822). 209–210. 15 indexed citations
19.
Shaw, T R, K Raymond, M. R. Howard, & John Hamer. (1973). Therapeutic Non-equivalence of Digoxin Tablets in United Kingdom: Correlation with Tablet Dissolution Rate. BMJ. 4(5895). 763–766. 33 indexed citations
20.
Raymond, K, et al.. (1973). Some observations on blood level data following oral administration of aspirin as tablets and capsules.. PubMed. 48(2). 336P–336P. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pekka Ottoila Breakdown of academic impact, for papers by Clarence T. Ueda Breakdown of academic impact, for papers by Chii‐Ming Lai Breakdown of academic impact, for papers by Dale A. Raines Breakdown of academic impact, for papers by D W Holt Breakdown of academic impact, for papers by Henry J. Pieniaszek Breakdown of academic impact, for papers by J.‐M. POIRIER Breakdown of academic impact, for papers by John J. Schrogie Breakdown of academic impact, for papers by Richard H. Reuning Breakdown of academic impact, for papers by S. M. Singhvi
Rankless by CCL
2026